Results 11 to 20 of about 37,549 (151)
Efficacy, Effectiveness, and Safety of Treatment Regimens for Histoplasmosis and Tuberculosis Coinfection in Patients With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: A Systematic Review With Meta-Analysis Protocol. [PDF]
Health Sci RepABSTRACT Background and Aims While previous publications have briefly pointed out a few alternative therapeutic interventions for the treatment of histoplasmosis and tuberculosis coinfections in patients with Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), there are no reviews evaluating the efficacy, effectiveness ...
Sarinho BB +5 more
europepmc +2 more sources
Extensive Lymphadenopathy in an HIV-Negative Patient With Multidrug-Resistant Tuberculosis. [PDF]
Respirol Case RepExtensive lymphadenopathy is uncommon in HIV‐negative patients with tuberculosis. This clinical image highlights the striking CT appearance of extensive extrapulmonary lymph node involvement in symptomatic multidrug‐resistant tuberculosis, even in the absence of HIV infection. ABSTRACT Tuberculous lymphadenitis is generally more severe in patients with
Araya T +5 more
europepmc +2 more sources
Data in Brief, 2020 This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia.
Ricvan Dana Nindrea +7 more
doaj +1 more source
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source
PLoS ONE, 2022 BackgroundThe rate of multidrug-resistant tuberculosis is increasing at an alarming rate throughout the world. It is becoming an emerging public health problem in East Africa.
Kindu Alem Molla +2 more
doaj +1 more source
Multidrug-resistant tuberculosis in middle ear: A case report
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023 Background: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB.
Tanze Cao +5 more
doaj +1 more source
Multidrug-resistant tuberculosis today [PDF]
Bulletin of the World Health Organization, 2012 The World Health Organization (WHO) and its partners have long conducted efforts to improve tuberculosis (TB) case surveillance and programme monitoring and evaluation. WHO’s 2011 report on global TB control1 provided the most reliable information ever generated on the burden of disease and death caused by TB and multidrug-resistant TB (i.e.
Matteelli, A. +3 more
openaire +4 more sources
SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC
Паёми Сино, 2018 Objective: To study the clinical course of tuberculosis (TB) with multiple drug resistance (MDR) in the treatment of short-term courses recommended by the WHO.
E.V. ZHDANOVA, G.K. TURDUMAMBETOVA
doaj +1 more source
International Journal of Infectious Diseases, 2022 Purpose: Multidrug-resistant tuberculosis continues to cause a public health crisis and remains a threat to health security. Drug resistance to anti-tuberculosis drugs remains a major public health problem that compromises the successes in the fight ...
P.K. Yanogo, A.L. Papique, N. Meda
doaj +1 more source
Brazilian Journal of Infectious Diseases, 2016 Multidrug-resistant tuberculosis (MDRTB) is a serious world health problem that limits public actions to control tuberculosis, because the most used anti-tuberculosis first-line drugs fail to stop mycobacterium spread.
Luita Nice Café Oliveira +5 more
doaj +1 more source